Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science (DHREAMS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Columbia University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Wendy K. Chung, Columbia University
ClinicalTrials.gov Identifier:
NCT00950118
First received: July 29, 2009
Last updated: November 19, 2012
Last verified: November 2012
  Purpose

Congenital diaphragmatic hernia (CDH) is a birth defect that occurs when the diaphragm (thin sheet of muscle that separates the abdomen from the chest) does not form properly. When an opening is present in the diaphragm, organs that are normally in the abdomen can be pushed (herniated) through the opening and be present in the chest. Currently little is known about why this birth defect occurs.

Through this study ""Molecular Genetic Analysis of Congenital Diaphragmatic Hernia" the investigators hope to learn more about whether certain genes contribute to CDH. Genes are the instructions or blueprints for our bodies. They tell our bodies how to grow and develop. Sometimes when a mistake occurs in one or more of our genes our body does not develop properly and this can lead to a CDH. The investigators hope that the information gained through studying the genes of children with CDH and their parents, will lead to significant advances in the diagnosis, prognosis, prevention, and treatment of this disease.


Condition
Congenital Diaphragmatic Hernia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science

Resource links provided by NLM:


Further study details as provided by Columbia University:

Primary Outcome Measures:
  • survival [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • development [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • growth [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • pulmonary hypertension [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

whole blood, tissue, saliva


Estimated Enrollment: 500
Study Start Date: June 2005
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Congenital Diaphragmatic Hernia (CDH)
Humans affected with congenital diaphragmatic hernia (CDH)
Unaffected
Healthy family members of individuals affected with congenital diaphragmatic hernia (CDH)

Detailed Description:

The goal of this study is to identify genes that convey susceptibility to congenital diaphragmatic hernia in humans. The identification of such genes, and examination of their structure and function, will enable a delineation of molecular pathogenesis and, ultimately, prevention or treatment of congenital diaphragmatic hernia. There are many different possible modes of inheritance for congenital anomalies, including autosomal dominant, autosomal recessive, and multifactorial. Multi-factorial inheritance is responsible for many common medical disorders, including hypertension, myocardial infarction, diabetes and cancer. This type of inheritance pattern appears to involve environmental factors as well as a combination of genetic variations that together can predispose to or produce congenital anomalies, such as congenital diaphragmatic hernia.

Our study is designed to establish a small, well-defined genetic resource consisting of 1)Nuclear families suitable for linkage analysis by parametric,non-parametric (e.g. sib pairs, TDT) and association techniques, 2) Individuals with congenital diaphragmatic hernia who can be directly screened for allelic variation in candidate genes, and 3) Individuals who can serve as controls (are unaffected by congenital diaphragmatic hernia). Neonates and their families will be collected from homogenous and heterogeneous populations. By characterizing diverse populations, it should be possible to increase the likelihood of demonstration of genetic variation in selected candidate genes that can then be used in association and linkage studies in individual subjects with congenital diaphragmatic hernia.

The focus will be on neonates recruited through clinical services at the New York Presbyterian Medical Center. Our recruitment efforts will be in collaboration with physicians in the Pediatric Surgery Department and the Neonatology Departments. The patients and their families will be recruited using the prenatally diagnosed babies born at CHONY and the babies born at outside institutions

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Children/neonates with an unrepaired congenital diaphragmatic hernia

Children/neonates with a reparied congenital diaphragmatic hernia

Women who are pregnant with a fetus diagnosed with congenital diaphragmatic hernia

Individuals with a family history of congenital diaphragmatic hernia

Criteria

Inclusion Criteria:

  • All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of a CDH

Exclusion Criteria:

  • Individuals with no personal history of a CDH or family history of a family member affected with congenital diaphragmatic hernia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00950118

Contacts
Contact: Julia Wynn, MS 212-305-6987 jw2500@columbia.edu
Contact: Wendy Chung, MD, PhD 212-305-6731 wkc15@columbia.edu

Locations
United States, Michigan
University of Michigan/ CS Mott Children's Hospital Recruiting
Ann Arbor, Michigan, United States, 48167-5245
Contact: George Mychalisa, MD, MS    734-763-2072    mychalis@med.umich.edu   
Contact: Jeannie Kreutzman, RN, MSN    734-763-2072    jkreutzm@med.umich.edu   
Principal Investigator: George Mychalisa, MD, MS         
United States, Missouri
Washington University Medical Center/ St. Louis Children's Hospital Recruiting
St. Louis, Missouri, United States, 63110
Contact: Brad Warner, MD    314-454-6022    warnerb@wudosis.wustl.edu   
Contact: Brian Bucher, MD    314-454-6022    bucherb@wudosis.wustl.edu   
Principal Investigator: Brad Warner, MD         
United States, Nebraska
Children's Hospital of Omaha/ University of Nebraska Recruiting
Omaha, Nebraska, United States, 68114
Contact: Kenneth Azarow, MD    402-955-7400    kazarow@childrensomaha.org   
Contact: Sheila Horak, APRN       shorak@childrensomaha.org   
Principal Investigator: Kenneth Azarow, MD         
United States, New York
Morgan Stanley Children's Hospital of New York- Presbyterian (Columbia University Medical Center) Recruiting
New York, New York, United States, 10032
Contact: Julia Wynn, MS    212-305-6987    jw2500@columbia.edu   
Contact: Wendy Chung, MD, PhD    212-851-5313    wkc15@columbia.edu   
Principal Investigator: Wendy Chung, MD, PhD         
Principal Investigator: Marc Arkovitz, MD         
United States, Ohio
Cincinnati Children's Hospital and Medical Center/ University of Cincinnati Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Gina Sharp, BSN    513-803-0745    gina.sharp@cchmc.org   
Contact: Bonnie Killen, BA    513-803-2219    bonnie.killen@cchmc.org   
Principal Investigator: Tim Crombleholme, MD         
United States, Pennsylvania
Children's Hospital of Pittsburgh/ University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Laurie Luther, BSN    412-692-7440    laurie.luther@chp.edu   
Contact: Douglas Potoka, MD       douglas.potoka@chp.edu   
Principal Investigator: Douglas Potoka, MD         
United States, Tennessee
Monroe Carrell Jr Children's Hospital at Vanderbilt Recruiting
Nashville, Tennessee, United States, 37232
Contact: Dai H Chung, MD    615-936-1050    dai.chung@vanderbilt.edu   
Contact: John Pietsch, MD    615-936-1050    john.pietsch@vanderbilt.edu   
Principal Investigator: Dai H Chung, MD         
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Wendy Chung, MD, PhD Columbia University
  More Information

Additional Information:
No publications provided by Columbia University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Wendy K. Chung, Assistant Professor, Department of Pediatrics Molecular Genetics, Columbia University
ClinicalTrials.gov Identifier: NCT00950118     History of Changes
Other Study ID Numbers: AAAB2063, R01HD057036
Study First Received: July 29, 2009
Last Updated: November 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Columbia University:
Congenital Diaphragmatic Hernia (CDH)
Genes
Genetic
chromosome
chromosome microarray
microarray

Additional relevant MeSH terms:
Hernia
Hernia, Diaphragmatic
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on November 20, 2014